Andlauer Healthcare Group (TSE:AND) PT Lowered to C$46.00 at Scotiabank

Andlauer Healthcare Group (TSE:ANDFree Report) had its target price trimmed by Scotiabank from C$47.50 to C$46.00 in a research note released on Monday morning, BayStreet.CA reports. The firm currently has an outperform rating on the stock.

A number of other brokerages have also recently commented on AND. CIBC reduced their target price on shares of Andlauer Healthcare Group from C$52.00 to C$50.00 and set an outperform rating for the company in a research report on Monday. Royal Bank of Canada decreased their target price on shares of Andlauer Healthcare Group from C$43.00 to C$41.00 and set a sector perform rating on the stock in a research note on Monday. Stifel Nicolaus dropped their price target on Andlauer Healthcare Group from C$55.00 to C$52.00 and set a buy rating for the company in a research report on Monday. Eight Capital reduced their price objective on Andlauer Healthcare Group from C$62.00 to C$58.00 and set a buy rating on the stock in a research report on Thursday, March 7th. Finally, TD Securities dropped their target price on Andlauer Healthcare Group from C$54.00 to C$52.00 and set a buy rating for the company in a report on Monday. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Andlauer Healthcare Group currently has an average rating of Moderate Buy and an average price target of C$49.43.

View Our Latest Research Report on Andlauer Healthcare Group

Andlauer Healthcare Group Price Performance

TSE:AND opened at C$39.55 on Monday. The stock has a 50 day moving average of C$42.10 and a two-hundred day moving average of C$40.51. Andlauer Healthcare Group has a 12 month low of C$36.76 and a 12 month high of C$48.80. The firm has a market cap of C$770.43 million, a P/E ratio of 25.52 and a beta of 0.69. The company has a current ratio of 2.52, a quick ratio of 1.66 and a debt-to-equity ratio of 27.24.

Andlauer Healthcare Group (TSE:ANDGet Free Report) last issued its quarterly earnings results on Tuesday, March 5th. The company reported C$0.44 EPS for the quarter, missing the consensus estimate of C$0.49 by C($0.05). Andlauer Healthcare Group had a return on equity of 14.53% and a net margin of 10.21%. The firm had revenue of C$169.07 million for the quarter, compared to analysts’ expectations of C$165.00 million. On average, analysts expect that Andlauer Healthcare Group will post 1.8439434 earnings per share for the current fiscal year.

Andlauer Healthcare Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Thursday, March 28th were paid a $0.10 dividend. This represents a $0.40 annualized dividend and a dividend yield of 1.01%. The ex-dividend date of this dividend was Wednesday, March 27th. This is a positive change from Andlauer Healthcare Group’s previous quarterly dividend of $0.09. Andlauer Healthcare Group’s dividend payout ratio is 23.23%.

Andlauer Healthcare Group Company Profile

(Get Free Report)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

See Also

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.